|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.24 USD | +0.33% |
|
+16.33% | +9.97% |
| Capitalization | 2.04B 1.73B 1.6B 1.5B 2.79B 189B 2.84B 18.71B 7.33B 91.13B 7.64B 7.48B 324B | P/E ratio 2026 * |
-19.9x | P/E ratio 2027 * | -18.6x |
|---|---|---|---|---|---|
| Enterprise value | 1.96B 1.66B 1.54B 1.45B 2.69B 182B 2.73B 18.01B 7.06B 87.74B 7.35B 7.2B 312B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 530x |
| Free-Float |
94.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sionna Therapeutics, Inc.
| 1 day | +0.33% | ||
| 1 week | +16.33% | ||
| Current month | +12.85% | ||
| 1 month | +21.71% | ||
| 3 months | +15.67% | ||
| 6 months | +38.26% | ||
| Current year | +9.97% |
| 1 week | 36.91 |  | 46.1 |
| 1 month | 33.2 | | 46.1 |
| Current year | 32.46 | | 46.1 |
| 1 year | 10.07 | | 46.1 |
| 3 years | 7.26 | | 46.1 |
| 5 years | 7.26 | | 46.1 |
| 10 years | 7.26 | | 46.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Munson
PRN | Corporate Officer/Principal | - | 2019-07-31 |
Greg Hurlbut
PRN | Corporate Officer/Principal | - | 2019-07-31 |
Michael Cloonan
CEO | Chief Executive Officer | 54 | 2021-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Joshua Resnick
BRD | Director/Board Member | 51 | 2019-11-30 |
Lucian Iancovici
BRD | Director/Board Member | 44 | 2019-11-30 |
Bruce Booth
BRD | Director/Board Member | 51 | 2020-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.33% | +16.33% | +352.40% | - | 2.04B | |
| -0.41% | +5.02% | -1.85% | -9.41% | 47.35B | |
| +0.24% | +2.32% | +40.57% | +21.48% | 35.57B | |
| -2.14% | +55.13% | +312.35% | +574.21% | 31.16B | |
| -3.45% | +1.76% | +15.84% | -14.18% | 28.86B | |
| +3.47% | +3.72% | +36.62% | +29.82% | 29.62B | |
| +0.51% | +0.51% | +53.62% | +199.31% | 15.01B | |
| -0.56% | +2.82% | +73.91% | +168.37% | 14.73B | |
| +2.55% | +8.52% | +4,163.00% | +4,049.02% | 15.12B | |
| -0.29% | +8.19% | +37.00% | +11.64% | 14.34B | |
| Average | +0.03% | +10.67% | +508.35% | +558.92% | 23.38B | |
| Weighted average by Cap. | -0.17% | +11.11% | +336.63% | +369.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 3.75M 3.18M 2.94M 2.77M 5.14M 349M 5.23M 34.46M 13.51M 168M 14.07M 13.77M 597M |
| Net income | -108M -91.96M -84.91M -80.05M -148M -10.08B -151M -995M -390M -4.85B -406M -398M -17.24B | -125M -106M -98.13M -92.52M -172M -11.65B -175M -1.15B -451M -5.6B -470M -460M -19.92B |
| Net Debt | -75.62M -64.22M -59.29M -55.9M -104M -7.04B -105M -695M -272M -3.39B -284M -278M -12.04B | -48.87M -41.5M -38.32M -36.12M -67.01M -4.55B -68.18M -449M -176M -2.19B -183M -180M -7.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-16 | 45.24 $ | +0.33% | 817,608 |
| 26-04-15 | 45.09 $ | +4.13% | 768,535 |
| 26-04-14 | 43.30 $ | +3.66% | 900,098 |
| 26-04-13 | 41.77 $ | +10.24% | 382,801 |
| 26-04-10 | 37.89 $ | -2.57% | 223,104 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SION Stock
Select your edition
All financial news and data tailored to specific country editions
